Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUGP2 (SURP and G-patch domain-containing protein 2) is a member of the arginine/serine-rich family of splicing factors, functioning as a chromatin-associated protein primarily involved in pre-mRNA processing and regulation of alternative splicing[1][3][5][7]. It localizes predominantly to the nucleus—especially in the testis and brain—and contains conserved SURP1/2 and G-patch domains, which confer RNA-binding and splicing regulation activity[1][2][6]. SUGP2 regulates the alternative splicing of genes related to ion and energy metabolism during spermatogenesis, but knockout models reveal it is dispensable for male fertility, with no major developmental or meiotic defects, indicating possible functional redundancy with its paralog SUGP1[1]. No direct link to human disease or therapeutic applications is currently established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SURP and G-patch domain-containing protein 2 (SUGP2).